Lake Street lowered the firm’s price target on Cardlytics (CDLX) to $3 from $5 and keeps a Hold rating on the shares. The firm believes the stock “remains in the proving grounds,” but adds it is encouraged by emerging better ad delivery performance and supply side inventory. The firm cites broader multiple compression in the space for its price target cut.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDLX: